Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,621,226
-
Share change
-
+481,372
-
Total reported value
-
$13,179,000
-
Price per share
-
$8.13
-
Number of holders
-
14
-
Value change
-
+$3,912,448
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) as of Q2 2015
As of 30 Jun 2015,
IMPRIMIS PHARMACEUTICALS INC - COM NEW (IMMY) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,621,226 shares.
The largest 10 holders included
Opaleye Management Inc., Granite Investment Partners, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, REGIONS FINANCIAL CORP, MARATHON CAPITAL MANAGEMENT, Granite Point Capital Management, L.P., BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.